Pigment epithelium-derived factor (PEDF) varies with body composition and insulin resistance in healthy young people

Kyle L Sunderland1, Jeanie B Tryggestad, Joshua J Wang

  • 1Metabolic Research Program, 1200 Children's Avenue, Suite 4500, Oklahoma City, Oklahoma 73104, USA.

Insights

Plasma Pigment Epithelium-Derived Factor (PEDF) is higher in overweight youth and linked to insulin resistance. This suggests PEDF may impact cardiometabolic health in children and young adults.

Area of Science:

  • Metabolic Health
  • Pediatrics
  • Endocrinology

Background:

  • Pigment Epithelium-Derived Factor (PEDF) is recognized as a metabolic regulator in adults.
  • Elevated plasma PEDF levels are observed in obese and insulin-resistant adults.
  • Circulating PEDF levels in children have not been previously reported, yet it may predict metabolic health in this demographic.

Purpose of the Study:

  • To investigate variations in PEDF levels based on age, sex, and body composition in normal-weight (NW) and overweight/obese (OW) children and young adults.
  • To determine the association between PEDF and clinical markers of metabolic disease in youth.
  • To explore PEDF's potential role in pediatric metabolic health.

Main Methods:

  • Cross-sectional study involving 91 NW and 105 OW participants aged 8-35 years.
  • Measurements included body composition, blood pressure, arterial compliance, and fasting plasma levels of PEDF, glucose, insulin, triglycerides, cholesterol, and C-reactive protein.
  • Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) was calculated.

Main Results:

  • Plasma PEDF was 60% higher in OW compared to NW participants, with no sex differences.
  • PEDF positively correlated with body mass, BMI, fat mass, lean mass, fasting insulin, and HOMA-IR in both groups.
  • Fat and lean mass were significant independent predictors of PEDF levels, irrespective of age, sex, or BMI category.

Conclusions:

  • Elevated plasma PEDF in overweight youth is associated with increased insulin resistance.
  • These findings indicate a potential role for PEDF in the development of cardiometabolic dysfunction among children and adolescents.
  • PEDF may serve as a biomarker for metabolic disturbances in pediatric populations.
Abstract